Aerovate Therapeutics (AVTE) Q2 2025 Earnings

14MayConfirmed
Q2 2024
Q3 2024
Q4 2024
Q2 2025
-12.1
-8.22
-4.34
-0.47

Details

Expected EPS
-6.025
Actual EPS
-12.1
Surprise EPS
-6.07
Surprise Percent
+100.83%

Description

Aerovate Therapeutics (AVTE) has reported earnings of -12.1 per share for Q2 2025.

0 Comments

Share your thoughts